Galectin-3 as an important prognostic marker for COVID-19 severity

Galectin-3 (Gal-3), multifunctional protein plays important roles in inflammatory response, infection and fibrosis. The goal of study was to determine the association of Gal-3, immune response, clinical, biochemical, and radiographic findings with COVID-19 severity. Study included 280 COVID-19 patients classified according to disease severity into mild, moderate, severe and critical group. Cytokines, clinical, biochemical, radiographic data and peripheral blood immune cell make up were analyzed. Patients in critical group had significantly higher serum level of Gal-3, IL-1 beta, TNF-alpha, IL-12, IL-10 compared to the patients in less severe stages of disease. Strong positive correlation was detected between Gal-3 and IL-1 beta, moderate positive correlation between Gal-3, TNF-alpha and IL-12, moderate negative correlation between Gal-3, IL-10/IL-1 beta and IL-10/TNF-alpha. Moderate positive correlation noted between Gal-3 and urea, D dimer, CXR findings. Strong negative correlation detected between Gal-3 and p0(2), Sa0(2,) and moderate negative correlation between Gal-3, lymphocyte and monocyte percentage. In the peripheral blood of patients with more severe stages of COVID-19 we detected significantly increased percentages of CD56(-) CD3(+)TNF-alpha T+ cells and CD56(-) CD3(+)Gal-3(+)T cells and increased expression of CCR5 in PBMCs. Our results predict Gal-3 as an important marker for critical stage of COVID-19. Higher expression of Gal-3, TNF-alpha and CCR5 on T cells implicate on promoting inflammation and more severe form of disease.

Automated summary

Gal-3 is associated with COVID-19 severity and immune response. Patients in critical stage have higher levels of Gal-3, cytokines, and CCR5 expression, indicating more severe inflammation. Gal-3 also correlates with clinical and radiographic findings, as well as peripheral blood immune cell composition.